Your browser doesn't support javascript.
loading
Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysis.
Luo, Yingying; Xia, Jun; Zhao, Zhan; Chang, Yaping; Bee, Yong Mong; Nguyen, Khue Thy; Lim, Soo; Yabe, Daisuke; McGill, Margaret; Kong, Alice Pik Shan; Chan, Siew Pheng; Deodat, Marisa; Deerochanawong, Chaicharn; Suastika, Ketut; Xu, Chenchen; Chen, Liming; Chen, Wei; Li, Xiaoying; Zhao, Weigang; Yao, Xiaomei; Ji, Linong.
Afiliação
  • Luo Y; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, 100044, China.
  • Xia J; Nottingham Ningbo GRADE Centre, University of Nottingham Ningbo China, Ningbo, Zhejiang, 315100, China.
  • Zhao Z; Academic Unit of Lifespan and Population Health, School of Medicine, The University of Nottingham, Nottingham, NG7 2UH, UK.
  • Chang Y; Tianjin Tiantian Biotechnology Co., Ltd., Tianjin, 300000, China.
  • Bee YM; OrthoEvidence Inc., Burlington, Ontario, L7N 3H8, Canada.
  • Nguyen KT; Department of Endocrinology, Singapore General Hospital, 169608, Singapore, Singapore.
  • Lim S; Ho Chi Minh University of Medicine and Pharmacy Medic Medical Center, Ho Chi Minh City, 700000, Vietnam.
  • Yabe D; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, 13620, South Korea.
  • McGill M; Departments of Diabetes, Endocrinology and Metabolism/Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
  • Kong APS; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, 501-1194, Japan.
  • Chan SP; Diabetes Centre, Royal Prince Alfred Hospital, Faculty of Medicine and Health University of Sydney, Sydney, New South Wales, 2050, Australia.
  • Deodat M; Division of Endocrinology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, 999077, China.
  • Deerochanawong C; Subang Jaya Medical Centre, Department of Medicine, University of Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.
  • Suastika K; Michael G. DeGroote Cochrane Canada and McMaster GRADE Centres, McMaster University, Hamilton, Ontario, L8V 5C2, Canada.
  • Xu C; College of Medicine, Rangsit University, Bangkok, 10400, Thailand.
  • Chen L; Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Udayana University, Prof. IGNG Ngoerah Hospital, Denpasar, Bali, 80114, Indonesia.
  • Chen W; Tianjin Tiantian Biotechnology Co., Ltd., Tianjin, 300000, China.
  • Li X; Chu Hsien-I Memorial (Metabolic Diseases) Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, 300134, China.
  • Zhao W; Department of Clinical Nutrition, Department of Health Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Peking Union Medical College Hospital, Beijing, 100730, China.
  • Yao X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Ji L; Department of Endocrinology, Peking Union Medical College Hospital, Beijing, 100730, China.
J Diabetes ; 15(5): 419-435, 2023 May.
Article em En | MEDLINE | ID: mdl-37038616
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article